Tech Company Financing Transactions

Allergen Research Funding Round

Allergen Research closed a $80 million Series B funding round on 3/12/2015. Investors included Foresite Capital, Adage Capital Management and Aisling Capital.

Transaction Overview

Company Name
Allergen Research
Announced On
3/12/2015
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series B
Investors

Foresite Capital (Lead Investor) (James Tananbaum)

Adage Capital Management

Aisling Capital (Stacey Seltzer)

Fidelity Management & Research Company

Longitude Capital Management (Patrick Enright)

Palo Alto Investors (Joon Yun)

RA Capital

Proceeds Purpose
ARC will use the proceeds to fund the upcoming Phase 3 clinical trial of ARC's lead product, AR 101, a standardized, pharmaceutical-grade peanut protein formulation for treating peanut allergy via characterized oral desensitization immunotherapy (CODIT). The company also plans to begin clinical trials for treatment of egg and milk allergies in the coming year.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2000 Alameda de las Pulgas 161
San Mateo, CA 94403
USA
Phone
(650) 614-5220
Website
www.allergenresearch.com
Email Address
Not Recorded
Overview
Allergen Research Corporation (ARC) develops treatments that protect children with food allergies from accidental exposure.
Profile
Allergen Research LinkedIn Company Profile
Social Media
Allergen Research Company Twitter Account
Company News
Allergen Research News
Facebook
Allergen Research on Facebook
YouTube
Allergen Research on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Dilly
  Stephen Dilly LinkedIn Profile  Stephen Dilly Twitter Account  Stephen Dilly News  Stephen Dilly on Facebook
Chief Marketing Officer
Robert Elfont
  Robert Elfont LinkedIn Profile  Robert Elfont Twitter Account  Robert Elfont News  Robert Elfont on Facebook
Chief Operating Officer
Howard Raff
  Howard Raff LinkedIn Profile  Howard Raff Twitter Account  Howard Raff News  Howard Raff on Facebook
VP - Operations
Joseph Suttner
  Joseph Suttner LinkedIn Profile  Joseph Suttner Twitter Account  Joseph Suttner News  Joseph Suttner on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/12/2015: Splash Events venture capital transaction
Next: 3/12/2015: HealthMyne venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.